Balance Sheet Breakdown: Arcturus Therapeutics Holdings Inc (ARCT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

After finishing at $25.96 in the prior trading day, Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) closed at $26.59, up 2.43%. In other words, the price has increased by $2.43 from its previous closing price. On the day, 1.82 million shares were traded. ARCT stock price reached its highest trading level at $26.65 during the session, while it also had its lowest trading level at $25.26.


Our goal is to gain a better understanding of ARCT by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 68.20. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 3.26. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on December 13, 2023, initiated with a Buy rating and assigned the stock a target price of $90.

On July 24, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $71.

H.C. Wainwright Upgraded its Neutral to Buy on May 11, 2023, whereas the target price for the stock was revised from $19 to $51.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 12 ’24 when SASSINE ANDY sold 50,000 shares for $32.03 per share. The transaction valued at 1,601,500 led to the insider holds 220,526 shares of the business.

Chivukula Pad sold 114 shares of ARCT for $5,130 on Jun 05 ’24. The Chief Scientific Officer & COO now owns 447,334 shares after completing the transaction at $45.00 per share. On Jun 03 ’24, another insider, Chivukula Pad, who serves as the Chief Scientific Officer & COO of the company, sold 26,000 shares for $40.01 each. As a result, the insider received 1,040,234 and left with 447,448 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARCT now has a Market Capitalization of 716116544 and an Enterprise Value of 459643264. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.30 while its Price-to-Book (P/B) ratio in mrq is 2.71. Its current Enterprise Value per Revenue stands at 3.691 whereas that against EBITDA is -3.853.

Stock Price History:

The Beta on a monthly basis for ARCT is 2.63, which has changed by 0.110693455 over the last 52 weeks, in comparison to a change of 0.2586832 over the same period for the S&P500. Over the past 52 weeks, ARCT has reached a high of $45.00, while it has fallen to a 52-week low of $17.52. The 50-Day Moving Average of the stock is -13.56%, while the 200-Day Moving Average is calculated to be -10.80%.

Shares Statistics:

The stock has traded on average 556.70K shares per day over the past 3-months and 885800 shares per day over the last 10 days, according to various share statistics. A total of 26.83M shares are outstanding, with a floating share count of 24.65M. Insiders hold about 8.46% of the company’s shares, while institutions hold 97.30% stake in the company. Shares short for ARCT as of 1715731200 were 4128904 with a Short Ratio of 7.39, compared to 1713139200 on 4613132. Therefore, it implies a Short% of Shares Outstanding of 4128904 and a Short% of Float of 24.110001.

Most Popular